Clínica Baviera, S.A.

MCE CBAV.MC

Clínica Baviera, S.A. Return on Equity (ROE) for the year ending December 31, 2023: 39.53%

Clínica Baviera, S.A. Return on Equity (ROE) is 39.53% for the year ending December 31, 2023, a -9.82% change year over year. Return on equity measures profit against shareholder equity; higher ROE indicates superior profitability and value creation.

Clínica Baviera, S.A. Return on Equity (ROE) for the year ending December 31, 2022 was 43.83%, a -12.62% change year over year.
Clínica Baviera, S.A. Return on Equity (ROE) for the year ending December 31, 2021 was 50.16%, a 60.08% change year over year.
Clínica Baviera, S.A. Return on Equity (ROE) for the year ending December 31, 2020 was 31.34%, a -25.08% change year over year.
Clínica Baviera, S.A. Return on Equity (ROE) for the year ending December 31, 2019 was 41.82%, a 0.74% change year over year.

Key data

Date	Return on Equity (ROE)	Return on Capital Employed (ROCE)	Interest Coverage Ratio	Debt to Equity Ratio

MCE: CBAV.MC

Clínica Baviera, S.A.

CEO	Mr. Eduardo Baviera Sabater
IPO Date	April 3, 2007
Location	Spain
Headquarters	Paseo de la Castellana 20
Employees	1,326
Sector	Consumer Discretionary
Industries Eyewear Dental Care Drugstores & Retail Pharmacies

Description

Clínica Baviera, S.A., a medical company, operates a network of ophthalmology clinics. The company is involved in the diagnosis, treatment, and monitoring of various types of visual disorders. Its clinics offers myopia, hyperopia, astigmatism, presbyopia, cataract, retina, pediatric ophthalmology, glaucoma, squint, cornea, neuroftalmología, vías lagrimales, and oculoplasty treatments. It operates approximately 90 centers in Spain, Germany, Austria, and Italy. The company is based in Madrid, Spain.

Key trends

Past 5 years